Search results
Results from the WOW.Com Content Network
Polymyositis and the associated inflammatory myopathies have an associated increased risk of cancer. [3] The features they found associated with an increased risk of cancer were older age, age greater than 45, male sex, difficulty swallowing, death of skin cells, cutaneous vasculitis, rapid onset of myositis (<4 weeks), elevated creatine kinase, higher erythrocyte sedimentation rate and higher ...
For myositis, which is caused by a viral infection, no treatment is typically needed. [4] For myositis caused by a bacterial infection, antibiotics can be used. [4] For myositis caused by a medication, it is important to stop using that medication. [4] There are a variety of treatment options available if myositis is caused by an autoimmune ...
There have been few randomized treatment trials, due to the relative rarity of inflammatory myopathies. [4] The goal of treatment is improvement in activities of daily living and muscle strength. Suppression of immune system activity (immunosuppression) is the treatment strategy. Patients with PM or DM almost always improve to some degree in ...
Polymyositis that does not respond to treatment is likely IBM. [35] Dermatomyositis shares a number of similar physical symptoms and histopathological traits as polymyositis, but exhibits a skin rash not seen in polymyositis or sIBM. It may have different root causes unrelated to either polymyositis or sIBM. [36]
Respiratory complications, infectious diseases like pneumonia, cancer, [60] cardiovascular disorders, [63] severe myositis, and interstitial lung disease are the main causes of death amongst anti Jo-1-positive patients. [10]
The development of complications depends on a number of factors, including the degree of vulnerability, susceptibility, age, health status, and immune system condition. Knowledge of the most common and severe complications of a disease, procedure, or treatment allows for prevention and preparation for treatment if they should occur.
This category reflects the organization of International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Generally, diseases outlined within the ICD-10 codes T80-T88 within Chapter XIX: Injury, poisoning and certain other consequences of external causes should be included in this category.
Scleromyositis, is an autoimmune disease (a disease in which the immune system attacks the body). People with scleromyositis have symptoms of both systemic scleroderma and either polymyositis or dermatomyositis, and is therefore considered an overlap syndrome.